Please use this identifier to cite or link to this item:
Title: Relation of quality of anticoagulation control with different management systems among patients with atrial fibrillation: Data from FANTASIIA Registry.
Authors: Roldán Rabadán, Inmaculada
Esteve-Pastor, María Asunción
Anguita-Sánchez, Manuel
Muñiz, Javier
Camacho Siles, José
Quesada, María Angustias
Ruiz Ortiz, Martín
Marín, Francisco
Martínez Sellés, Manuel
Bertomeu, Vicente
Lip, Gregory Y H
Cequier Fillat, Angel
Badimón, Lina
FANTASIIA Study Investigators
Keywords: anticoagulation quality;atrial fibrillation;general practitioners;haematologists
metadata.dc.subject.mesh: Aged
Atrial Fibrillation
Cardiomyopathy, Dilated
Electric Countershock
General Practice
Heart Failure
Prospective Studies
Quality of Health Care
Risk Factors
Vitamin K
Issue Date: 11-Mar-2018
Abstract: Anticoagulation control in patients with atrial fibrillation (AF) has a multidisciplinary approach although is usually managed by general practitioners (GP) or haematologists. The aim of our study was to assess the quality of anticoagulation control with vitamin K antagonists (VKAs) in relation to the responsible specialist in a "real-world" AF population. We consecutively enrolled VKA anticoagulated patients included in the FANTASIIA Registry from 2013 to 2015. We analysed demographical, clinical characteristics and the quality of anticoagulation control according to the specialist responsible (ie GPs or haematologists). Data on 1584 patients were included (42.5% females, mean age 74.0 ± 9.4 years): 977 (61.7%) patients were controlled by GPs and 607 (38.3%) by haematologists. Patients managed by GPs had higher previous heart disease (53.2% vs 43.3%, P  About 60% of AF patients anticoagulated with VKAs had poor anticoagulation control (ie TTR
metadata.dc.identifier.doi: 10.1111/eci.12910
Appears in Collections:Producción 2020

Files in This Item:
There are no files associated with this item.

This item is protected by original copyright

Except where otherwise noted, Items on the Andalusian Health Repository site are licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives License.